摘要
基因转染是一种强有力的DNA传递的方法,能提供多种医疗应用,其中最有前景的是DNA疫苗和癌症的基因治疗。电穿孔需要应用电场到细胞,之后膜通透性经历局部和瞬时的变化。虽然基因转染在体外和体内的环境已被广泛的研究,DNA进入和通过细胞的机制尚不完全清楚。在这里,我们呈现了近三十年来累积的关于基因转染的知识体系的全方面的综述。为此,在简要回顾基因转染可提供的医疗应用之后,我们概括了膜的电通透作用,即用于DNA与小分子传递的关键过程。由于基因转染是一个复合过程,我们接着逐步地论述了我们当前的理解,特别强调了DNA的内在化和胞内运输。最后,我们关注了基因转染的在体检测和方法学。
关键词: 电场,电穿孔,基因转染,质粒DNA,基因治疗,DNA疫苗
Current Gene Therapy
Title:Gene Electrotransfer: A Mechanistic Perspective
Volume: 16 Issue: 2
Author(s): Christelle Rosazza, Sasa Haberl Meglic, Andreas Zumbusch, Marie-Pierre Rols, Damijan Miklavcic
Affiliation:
关键词: 电场,电穿孔,基因转染,质粒DNA,基因治疗,DNA疫苗
摘要: Gene electrotransfer is a powerful method of DNA delivery offering several medical applications, among the most promising of which are DNA vaccination and gene therapy for cancer treatment. Electroporation entails the application of electric fields to cells which then experience a local and transient change of membrane permeability. Although gene electrotransfer has been extensively studied in in vitro and in vivo environments, the mechanisms by which DNA enters and navigates through cells are not fully understood. Here we present a comprehensive review of the body of knowledge concerning gene electrotransfer that has been accumulated over the last three decades. For that purpose, after briefly reviewing the medical applications that gene electrotransfer can provide, we outline membrane electropermeabilization, a key process for the delivery of DNA and smaller molecules. Since gene electrotransfer is a multipart process, we proceed our review in describing step by step our current understanding, with particular emphasis on DNA internalization and intracellular trafficking. Finally, we turn our attention to in vivo testing and methodology for gene electrotransfer.
Export Options
About this article
Cite this article as:
Christelle Rosazza, Sasa Haberl Meglic, Andreas Zumbusch, Marie-Pierre Rols, Damijan Miklavcic , Gene Electrotransfer: A Mechanistic Perspective, Current Gene Therapy 2016; 16 (2) . https://dx.doi.org/10.2174/1566523216666160331130040
DOI https://dx.doi.org/10.2174/1566523216666160331130040 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antibodies for Therapeutic Uses and the Evolution of Biotechniques
Current Medicinal Chemistry Repositioning of Difluorinated Propanediones as Inhibitors of Histone Methyltransferases and their Biological Evaluation in Human Leukemic Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Human Immunodeficiency Virus-Associated Malignancies: A Therapeutic Update
Current HIV Research Inhibition of Sphingomyelin Hydrolysis: Targeting the Lipid Mediator Ceramide as a Key Regulator of Cellular Fate
Current Medicinal Chemistry Machine Learning for Childhood Acute Lymphoblastic Leukaemia Gene Expression Data Analysis: A Review
Current Bioinformatics Optimization of Lentiviral Vectors Generation for Biomedical and Clinical Research Purposes: Contemporary Trends in Technology Development and Applications
Current Gene Therapy β-Adrenergic Over-Stimulation and Cardio-Myocyte Apoptosis: Two Receptors, One Organelle, Two Fates?
Current Drug Targets Different Concepts of Drug Delivery in Disease Entities
Mini-Reviews in Medicinal Chemistry Antibody-Targeted Immunotherapy for Treatment of Non-Hodgkins Lymphoma
Current Pharmaceutical Biotechnology On the Involvement of H2S in Nitroso Signaling and Other Mechanisms of H2S Action
Current Pharmaceutical Biotechnology Omacetaxine as an Anticancer Therapeutic: What is Old is New Again
Current Pharmaceutical Design Neurotrophic Actions of Mood-Stabilizers: A Recent Research Discovery and its Potential Clinical Applications
Current Psychiatry Reviews Host Innate Immune Responses to Microbial Pathogens
Current Vascular Pharmacology Preparation and Characterization of Bifunctional Nanoparticles of Vitamin E TPGS-emulsified PLGA-PEG-FOL Containing Deferasirox
Nanoscience & Nanotechnology-Asia Review: The JAK/STAT Protein Activation – Role in Cancer Development and Targeted Therapy
Current Signal Transduction Therapy Withdrawal Notice: Recent Developments in Anti-Cancer Activity of Compounds Containing the Thioether Group
Anti-Cancer Agents in Medicinal Chemistry Biological Drugs in Guillain-Barré Syndrome: An Update
Current Neuropharmacology Edelfosine in Membrane Environment - the Langmuir Monolayer Studies
Anti-Cancer Agents in Medicinal Chemistry Plant-Made Antibodies: Properties and Therapeutic Applications
Current Medicinal Chemistry Metal Protein Attenuating Compounds (MPACs): An Emerging Approach for the Treatment of Neurodegenerative Disorders
Current Bioactive Compounds